Cite
HARVARD Citation
Yu, K. et al. (2021). Pharmacokinetic equivalence of CT‐P17 to high‐concentration (100 mg/ml) reference adalimumab: A randomized phase I study in healthy subjects. Clinical and translational science. 14 (4), pp. 1280-1291. [Online].